Hyderabad-based Bharat Biotech to develop intranasal vaccine for Coronavirus
The vaccine, likely to be named CoroFlu, will be built on a flu vaccine backbone named M2SR, which has already proved to be safe and well tolerant when given to humans, in Phase I and II of the clinical trials.
Apr 04, 2020, 12:40 PM IST